{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T15:41:19Z","timestamp":1793202079043,"version":"4.5.0"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/igo\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.canep.2022.102203","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T12:39:23Z","timestamp":1655469563000},"page":"102203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"special_numbering":"C","title":["Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"79","author":[{"given":"Lauren K.","family":"Dillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucero","family":"Lopez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo X.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"Fullerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Chadha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2022.102203_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canep.2022.102203_bib2","series-title":"World Cancer Report 2014","author":"McGuire","year":"2015"},{"key":"10.1016\/j.canep.2022.102203_bib3","unstructured":"World Health Organization. WHO model lists of essential medicines. \u3008Https:\/\/Www.WhoInt\/Groups\/Expert-Committee-on-Selection-%20and-Use-of-Essential-Medicines\/Essential-Medicines-Lists\u3009; 2019 [accessed 25 July 2021]."},{"key":"10.1016\/j.canep.2022.102203_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1055\/s-0039-1684048","article-title":"Mechanisms of cisplatin-induced ototoxicity and prevention","volume":"40","author":"Rybak","year":"2019","journal-title":"Semin Hear"},{"key":"10.1016\/j.canep.2022.102203_bib5","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/ar.22577","article-title":"Review:\u00a0ototoxic characteristics of platinum antitumor drugs","volume":"295","author":"Ding","year":"2012","journal-title":"Anat. Rec."},{"key":"10.1016\/j.canep.2022.102203_bib6","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.tips.2013.05.006","article-title":"Understanding platinum-induced ototoxicity","volume":"34","author":"Langer","year":"2013","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.canep.2022.102203_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/2473974X20923580","article-title":"How the world\u2019s children hear: a narrative review of school hearing screening programs globally","volume":"4","author":"Yong","year":"2020","journal-title":"OTO Open"},{"key":"10.1016\/j.canep.2022.102203_bib8","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0140-6736(07)60602-3","article-title":"Global burden of childhood hearing impairment and disease control priorities for developing countries","volume":"369","author":"Olusanya","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.canep.2022.102203_bib9","doi-asserted-by":"crossref","first-page":"S256","DOI":"10.1093\/geront\/gnw033","article-title":"Aging and hearing health: the life-course approach","volume":"56","author":"Davis","year":"2016","journal-title":"Gerontologist"},{"key":"10.1016\/j.canep.2022.102203_bib10","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.canep.2022.102203_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1994.240","article-title":"Quality of life assessment in clinical cancer research","volume":"70","author":"Olschewski","year":"1994","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canep.2022.102203_bib12","unstructured":"World Health Organization. World Report on Hearing. 2021."},{"key":"10.1016\/j.canep.2022.102203_bib13","unstructured":"Chestnov O., Chadha S., Mariotti SP, Kocur I. Multi-country assessment of national capacity to provide hearing care. 2013."},{"key":"10.1016\/j.canep.2022.102203_bib14","author":"United Nations","year":"2015","journal-title":"Sustain. Dev. Goals"},{"key":"10.1016\/j.canep.2022.102203_bib15","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.apmr.2019.08.468","article-title":"Rehabilitation Is a global health priority","volume":"101","author":"Heinemann","year":"2020","journal-title":"Arch. Phys. Med Rehabil."},{"key":"10.1016\/j.canep.2022.102203_bib16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.canep.2022.102203_bib17","unstructured":"American Speech Language Hearing Association. Audiologic management of individuals receiving cochleotoxic drug therapy: Guidelines; 1994. Available from asha.org\/policy."},{"key":"10.1016\/j.canep.2022.102203_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-3-25","article-title":"The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews","volume":"3","author":"Whiting","year":"2003","journal-title":"BMC Med Res Method."},{"key":"10.1016\/j.canep.2022.102203_bib19","first-page":"97","article-title":"Cisplatin-based chemotherapy of human cancers","volume":"11","author":"Brown","year":"2019","journal-title":"J. Canc Ther."},{"key":"10.1016\/j.canep.2022.102203_bib20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00431-019-03566-7","article-title":"Inequalities in diagnosis and registration of pediatric very rare tumors: a European study on pleuropulmonary blastoma","volume":"179","author":"Grigoletto","year":"2020","journal-title":"Eur. J. Pedia"},{"key":"10.1016\/j.canep.2022.102203_bib21","series-title":"Cancer Treatment & Survivorship Facts & Figures 2019-2021","author":"American Cancer Society","year":"2019"},{"key":"10.1016\/j.canep.2022.102203_bib22","author":"Cancer Research UK","year":"2019","journal-title":"Our Res. Cancer Type"},{"key":"10.1016\/j.canep.2022.102203_bib23","first-page":"721","article-title":"Treatment trends in head and neck cancer: surveillance, epidemiology, and end results (SEER) patterns of care analysis","volume":"30","author":"Schlichting","year":"2019","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.canep.2022.102203_bib24","unstructured":"World Health Organization. World cancer report: Cancer research for cancer prevention. 2020."},{"key":"10.1016\/j.canep.2022.102203_bib25","unstructured":"World Bank. Population 2020. 2020. \u3008https:\/\/databank.worldbank.org\/data\/download\/POP.pdf\u3009."},{"key":"10.1016\/j.canep.2022.102203_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jinf.2021.05.010","article-title":"Prevalence of aminoglycoside-induced hearing loss in drug-resistant tuberculosis patients: a systematic review","volume":"83","author":"Dillard","year":"2021","journal-title":"J. Infect."},{"key":"10.1016\/j.canep.2022.102203_bib27","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/pbc.24236","article-title":"The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy","volume":"60","author":"Abujamra","year":"2013","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.canep.2022.102203_bib28","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ijporl.2010.05.011","article-title":"Cisplatinum ototoxicity in children, long-term follow up","volume":"74","author":"Al-Khatib","year":"2010","journal-title":"Int J. Pedia Otorhinolaryngol."},{"key":"10.1016\/j.canep.2022.102203_bib29","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.ijrobp.2008.07.034","article-title":"Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis","volume":"73","author":"Chan","year":"2009","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canep.2022.102203_bib30","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/cncr.21683","article-title":"Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma","volume":"106","author":"Chen","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2022.102203_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejca.2016.09.023","article-title":"Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study","volume":"69","author":"Clemens","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canep.2022.102203_bib32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/MPH.0b013e318059c220","article-title":"Ototoxicity from cisplatin therapy in childhood cancer","volume":"29","author":"Coradini","year":"2007","journal-title":"J. Pedia Hematol. Oncol."},{"key":"10.1016\/j.canep.2022.102203_bib33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1808-8694(15)30572-3","article-title":"High frequency audiometric study in cancer-cured patients treated with cisplatin","volume":"74","author":"Almeida","year":"2008","journal-title":"Braz. J. Otorhinolaryngol."},{"key":"10.1016\/j.canep.2022.102203_bib34","first-page":"65","article-title":"Hepatoblastoma in children aged less than six months at diagnosis: a report from the SIOPEL group","author":"Dall\u2019Igna","year":"2018","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.canep.2022.102203_bib35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/MPH.0b013e31815d1d83","article-title":"Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens","volume":"30","author":"Dean","year":"2008","journal-title":"J. Pedia Hematol. Oncol."},{"key":"10.1016\/j.canep.2022.102203_bib36","first-page":"4","article-title":"Audiological findings in patients treated with radio- and concomitant chemotherapy for head and neck tumors","author":"Dell\u2019Aringa","year":"2009","journal-title":"Radiat. Oncol."},{"issue":"3","key":"10.1016\/j.canep.2022.102203_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.14238\/pi55.3.2015.121-5","article-title":"Prevalence and risk factors of hearing loss in children with solid tumors treated with platinum-based chemotherapy","volume":"55","author":"Edward","year":"2015","journal-title":"Paediatr. Indones."},{"issue":"6","key":"10.1016\/j.canep.2022.102203_bib38","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/lary.23336","article-title":"Effect of cisplatin on distortion product otoacoustic emissions in Japanese patients","volume":"122","author":"Eiamprapai","year":"2012","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canep.2022.102203_bib39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4103\/0019-509X.55551","article-title":"Cisplatin-based chemotherapy: add high-frequency audiometry in the regimen","volume":"46","author":"Arora","year":"2009","journal-title":"Indian J. Cancer"},{"key":"10.1016\/j.canep.2022.102203_bib40","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/pbc.22876","article-title":"Hearing impairment after platinum\u2010based chemotherapy in childhood","volume":"56","author":"Einarsson","year":"2011","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.canep.2022.102203_bib41","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3109\/14992027.2010.485595","article-title":"Long term hearing degeneration after platinum-based chemotherapy in childhood","volume":"49","author":"Einarsson","year":"2010","journal-title":"Int J. Audio"},{"key":"10.1016\/j.canep.2022.102203_bib42","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000442435","article-title":"Audiological monitoring in children treated with platinum chemotherapy","volume":"21","author":"Fetoni","year":"2016","journal-title":"Audio Neurotol."},{"key":"10.1016\/j.canep.2022.102203_bib43","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1200\/JCO.2016.66.8822","article-title":"Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer","volume":"34","author":"Frisina","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canep.2022.102203_bib44","first-page":"345","article-title":"Platinum-induced ototoxicity in children and adolescents with cancer","volume":"5","author":"Gunes","year":"2009","journal-title":"J. Int Adv. Otol."},{"key":"10.1016\/j.canep.2022.102203_bib45","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s12070-016-0985-1","article-title":"Effects of chemoradiation on rearing in patients with head and neck malignancies: experience at a tertiary referral care hospital","volume":"68","author":"Jain","year":"2016","journal-title":"Indian J. Otolaryngol. Head. Neck Surg."},{"key":"10.1016\/j.canep.2022.102203_bib46","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/pbc.21898","article-title":"Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma","volume":"52","author":"Jehanne","year":"2009","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.canep.2022.102203_bib47","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4103\/0971-7749.167411","article-title":"Auditory alterations following chemoradiotherapy: a comparative study between cisplatin and paclitaxel","volume":"21","author":"Kaul","year":"2015","journal-title":"Indian J. Otol."},{"key":"10.1016\/j.canep.2022.102203_bib48","first-page":"151","article-title":"Ototoxicity in children receiving platinum chemotherapy: Underestimating a commonly occuring toxicity that may influence academic and social development","volume":"11","author":"Knight","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canep.2022.102203_bib49","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1200\/JCO.2006.07.9723","article-title":"Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions","volume":"25","author":"Knight","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canep.2022.102203_bib50","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1017\/S0022215115001632","article-title":"Sensorineural hearing loss following induction chemotherapy plus concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma","volume":"129","author":"Atchariyasathian","year":"2015","journal-title":"J. Laryngol. Otol."},{"issue":"2","key":"10.1016\/j.canep.2022.102203_bib51","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/MPH.0b013e3181cb8593","article-title":"Late onset hearing loss: a significant complication of cancer survivors treated with Cisplatin containing chemotherapy regimens","volume":"32","author":"Kolinsky","year":"2010","journal-title":"J. Pedia Hematol. Oncol."},{"key":"10.1016\/j.canep.2022.102203_bib52","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/cncr.22004","article-title":"Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma","volume":"107","author":"Kushner","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2022.102203_bib53","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.2013.51.2038","article-title":"Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales - A report from the Children\u2019s Oncology Group","volume":"32","author":"Landier","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canep.2022.102203_bib54","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00381-010-1300-1","article-title":"Carboplatin and ototoxicity: hearing loss rates among survivors of childhood medulloblastoma","volume":"27","author":"Musial-Bright","year":"2011","journal-title":"Child\u2019s Nerv. Syst."},{"key":"10.1016\/j.canep.2022.102203_bib55","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3892\/ol.2012.997","article-title":"Prospective evaluation of cisplatin- and carboplatin-mediated ototoxicity in paediatric and adult soft tissue and osteosarcoma patients","volume":"5","author":"Nitz","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canep.2022.102203_bib56","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/pbc.23275","article-title":"Hearing loss among survivors of childhood brain tumors treated with an irradiation-sparing approach","volume":"58","author":"Orgel","year":"2012","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.canep.2022.102203_bib57","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/pbc.25804","article-title":"Effect of sensorineural hearing loss on neurocognitive functioning in pediatric brain tumor survivors","volume":"63","author":"Orgel","year":"2016","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.canep.2022.102203_bib58","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.ijrobp.2009.09.031","article-title":"Ototoxicity after intensity-modulated radiation therapy and cisplatin-based chemotherapy in children with medulloblastoma","volume":"78","author":"Paulino","year":"2010","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canep.2022.102203_bib59","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12094-011-0665-2","article-title":"Evaluation of ototoxicity in children treated for retinoblastoma: Preliminary results of a systematic audiological evaluation","volume":"13","author":"Pecora Liberman","year":"2011","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.canep.2022.102203_bib60","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/pbc.25123","article-title":"Incidence of platinum-induced ototoxicity in pediatric patients in Quebec","volume":"61","author":"Peleva","year":"2014","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.canep.2022.102203_bib61","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/pbc.20379","article-title":"Long-term renal and hearing toxicity of carboplatin in infants treated for localized and unresectable neuroblastoma: Results of the SFOP NBL90 study","volume":"45","author":"Bergeron","year":"2005","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.canep.2022.102203_bib62","first-page":"6","article-title":"Sensorineural hearing loss after concurrent chemoradiotherapy in nasopharyngeal cancer patients","author":"Petsuksiri","year":"2011","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.canep.2022.102203_bib63","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1200\/JCO.2011.36.9744","article-title":"Carboplatin-associated ototoxicity in children with retinoblastoma","volume":"30","author":"Qaddoumi","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canep.2022.102203_bib64","first-page":"634","article-title":"Report on hearing loss in oncology","volume":"75","author":"Schultz","year":"2009","journal-title":"Braz. J. Otorhinolaryngol."},{"key":"10.1016\/j.canep.2022.102203_bib65","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s00066-017-1205-y","article-title":"Impact of radiation technique, radiaction fraction dose, and total cisplatin dose on hearing","volume":"193","author":"Scobioala","year":"2017","journal-title":"Strahl. Onkol."},{"key":"10.1016\/j.canep.2022.102203_bib66","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jmir.2016.11.005","article-title":"Risk profiles for sensorineural hearing loss in patients with head and neck cancer receiving cisplatin-based chemoradiation","volume":"48","author":"Shorter","year":"2017","journal-title":"J. Med Imaging Radiat. Sci."},{"key":"10.1016\/j.canep.2022.102203_bib67","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/MPH.0b013e31821f0eaf","article-title":"Survival and long-term outcomes in children with hepatoblastoma treated with continuous infusion of cisplatin and doxorubicin","volume":"33","author":"Sivaprakasam","year":"2011","journal-title":"Pedia Hematol. Oncol. J."},{"key":"10.1016\/j.canep.2022.102203_bib68","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ygyno.2017.02.006","article-title":"Long-term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer","volume":"145","author":"Skalleberg","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canep.2022.102203_bib69","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejca.2005.11.004","article-title":"Assessment of hearing in very young children receiving carboplatin for retinoblastoma","volume":"42","author":"Smits","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canep.2022.102203_bib70","first-page":"65","article-title":"Clinical and genetic associations for carboplatin-related ototoxicity in children treated for retinoblastoma: a retrospective noncomparative single-institute experience","author":"Soliman","year":"2018","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.canep.2022.102203_bib71","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1002\/lary.24802","article-title":"Long-term hearing loss after chemoradiation in patients with head and neck cancer","volume":"124","author":"Theunissen","year":"2014","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canep.2022.102203_bib72","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000343909","article-title":"Time-frequency analysis of transient-evoked otoacoustic emissions in children exposed to carboplatin chemotherapy","volume":"18","author":"Bhagat","year":"2013","journal-title":"Audio Neurotol."},{"key":"10.1016\/j.canep.2022.102203_bib73","doi-asserted-by":"crossref","first-page":"158","DOI":"10.5935\/0946-5448.20120028","article-title":"Auditory brainstem responses (ABR) changes in children treated with high doses cisplatin","volume":"17","author":"Viana","year":"2012","journal-title":"Int Tinnitus J."},{"key":"10.1016\/j.canep.2022.102203_bib74","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijporl.2018.01.028","article-title":"Long term platinum-induced ototoxicity in pediatric patients","volume":"107","author":"Waissbluth","year":"2018","journal-title":"Int J. Pedia Otorhinolaryngol."},{"key":"10.1016\/j.canep.2022.102203_bib75","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.tranon.2015.10.003","article-title":"Sensorineural hearing loss after combined intensity modulated radiation therapy and cisplatin-based chemotherapy for nasopharyngeal carcinoma","volume":"8","author":"Wang","year":"2015","journal-title":"Transl. Oncol."},{"issue":"3","key":"10.1016\/j.canep.2022.102203_bib76","first-page":"191","article-title":"Cisplatin and cranial irradiation-related hearing loss in children","volume":"12","author":"Warrier","year":"2012","journal-title":"Ochsner J."},{"key":"10.1016\/j.canep.2022.102203_bib77","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijporl.2011.10.020","article-title":"Progressive hearing loss after completion of cisplatin chemotherapy is common and more pronounced in children without spontaneous otoacoustic emissions before chemotherapy","volume":"76","author":"Weissenstein","year":"2012","journal-title":"Int J. Pedia Otorhinolaryngol."},{"key":"10.1016\/j.canep.2022.102203_bib78","doi-asserted-by":"crossref","first-page":"288","DOI":"10.7196\/SAMJ.7389","article-title":"High prevalence of cisplatin-induced ototoxicity in Cape Town, South Africa","volume":"104","author":"Whitehorn","year":"2014","journal-title":"South Afr. Med J."},{"key":"10.1016\/j.canep.2022.102203_bib79","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/pbc.24138","article-title":"Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients","volume":"59","author":"Yancey","year":"2012","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.canep.2022.102203_bib80","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MPH.0000000000000028","article-title":"Cisplatin-induced hearing loss: the need for a long-term evaluating system","volume":"36","author":"Yasui","year":"2014","journal-title":"Pedia Hematol. Oncol. J."},{"key":"10.1016\/j.canep.2022.102203_bib81","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.radonc.2008.06.003","article-title":"Chemoradiotherapy of HN cancer Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer","volume":"89","author":"Zuur","year":"2008","journal-title":"Radio. Oncol."},{"key":"10.1016\/j.canep.2022.102203_bib82","first-page":"85","article-title":"Early detection of platinum-induced ototoxicity in adults","volume":"13","author":"D\u2019heygere","year":"2017","journal-title":"B-ENT"},{"key":"10.1016\/j.canep.2022.102203_bib83","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1002\/cncr.29604","article-title":"Treatment-induced hearing loss and adult social outcomes in survivors of childhood CNS and non-CNS solid tumors: results from the St. Jude Lifetime Cohort Study","volume":"121","author":"Brinkman","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2022.102203_bib84","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/BF03008019","article-title":"Study of the effects of chemotherapy on auditory function","volume":"57","author":"Dutta","year":"2005","journal-title":"Indian J. Otolaryngol. Head. Neck Surg."},{"key":"10.1016\/j.canep.2022.102203_bib85","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3109\/13816810.2015.1137325","article-title":"Long-term audiologic follow-up of carboplatin-treated children with retinoblastoma","volume":"38","author":"Geurtsen","year":"2017","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.canep.2022.102203_bib86","first-page":"7","article-title":"Ototoxicity evaluation in medulloblastoma patients treated with involved field boost using intensity-modulated radiation therapy (IMRT): a retrospective review Wilson","author":"Vieira","year":"2012","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.canep.2022.102203_bib87","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.ijrobp.2007.01.042","article-title":"Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis","volume":"68","author":"Zuur","year":"2007","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canep.2022.102203_bib88","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1002\/cncr.27395","article-title":"Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults","author":"Buehrlen","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2022.102203_bib89","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000468522","article-title":"The role of audiometry prior to high-dose cisplatin in patients with head and neck cancer","volume":"93","author":"Caballero","year":"2017","journal-title":"Oncol"},{"key":"10.1016\/j.canep.2022.102203_bib90","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.ijporl.2014.06.007","article-title":"Hearing loss in Mexican children treated with cisplatin","volume":"78","author":"Castel\u00e1n-Mart\u00ednez","year":"2014","journal-title":"Int J. Pedia Otorhinolaryngol."},{"key":"10.1016\/j.canep.2022.102203_bib91","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nrc1633","article-title":"Childhood solid tumours: a developmental disorder","volume":"5","author":"Scotting","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canep.2022.102203_bib92","first-page":"14","article-title":"A comparison of the Muenster, SIOP Boston, Brock, Chang and CTCAEv4.03 ototoxicity grading scales applied to 3,799 audiograms of childhood cancer patients treated with platinum-based chemotherapy","author":"Clemens","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.canep.2022.102203_bib93","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ijrobp.2006.09.017","article-title":"Ototoxicity after radiotherapy for head and neck tumors","volume":"67","author":"Bhandare","year":"2007","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canep.2022.102203_bib94","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.ejca.2003.08.009","article-title":"Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose","volume":"40","author":"Li","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canep.2022.102203_bib95","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/AUD.0000000000000536","article-title":"Long-term variability of distortion-product otoacoustic emissions in infants and children and its relation to pediatric ototoxicity monitoring","volume":"41","author":"Konrad-Martin","year":"2019","journal-title":"Ear Hear"},{"key":"10.1016\/j.canep.2022.102203_bib96","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/14992027.2015.1094188","article-title":"Ototoxicity (cochleotoxicity) classifications: a review","volume":"55","author":"Crundwell","year":"2016","journal-title":"Int J. Audio"},{"key":"10.1016\/j.canep.2022.102203_bib97","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00405-016-4117-z","article-title":"Platinum-induced ototoxicity: a review of prevailing ototoxicity criteria","volume":"274","author":"Waissbluth","year":"2017","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"key":"10.1016\/j.canep.2022.102203_bib98","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/ar.22578","article-title":"Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention","volume":"295","author":"Schacht","year":"2012","journal-title":"Anat. Rec."},{"key":"10.1016\/j.canep.2022.102203_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2019.00300","article-title":"Local drug delivery for prevention of hearing loss","volume":"13","author":"Rybak","year":"2019","journal-title":"Front Cell Neurosci."},{"key":"10.1016\/j.canep.2022.102203_bib100","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00106-019-0663-1","article-title":"Pharmacological intervention in the field of ototoxicity","author":"Laurell","year":"2019","journal-title":"HNO"},{"key":"10.1016\/j.canep.2022.102203_bib101","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1007\/s00405-020-06003-w","article-title":"Clinical trials evaluating transtympanic otoprotectants for cisplatin-induced ototoxicity: what do we know so far?","volume":"277","author":"Waissbluth","year":"2020","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"key":"10.1016\/j.canep.2022.102203_bib102","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.18895","article-title":"Association of sodium thiosulfate with risk of ototoxic effects from platinum-based chemotherapy: A systematic review and meta-analysis","author":"Chen","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.canep.2022.102203_bib103","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2352-4642(19)30115-4","article-title":"Interventions for cisplatin-induced hearing loss in children and adolescents with cancer","volume":"3","author":"Freyer","year":"2019","journal-title":"Lancet Child Adolesc. Heal"},{"key":"10.1016\/j.canep.2022.102203_bib104","first-page":"43","article-title":"Ototoxic hearing loss from antimalarials: a systematic narrative review","author":"Dillard","year":"2021","journal-title":"Travel Med Infect. Dis."},{"key":"10.1016\/j.canep.2022.102203_bib105","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1080\/14992027.2019.1660918","article-title":"Cancer survivors treated with platinum-based chemotherapy affected by ototoxicity and the impact on quality of life: a narrative synthesis systematic review","volume":"58","author":"Pearson","year":"2019","journal-title":"Int J. Audio"},{"key":"10.1016\/j.canep.2022.102203_bib106","first-page":"1207","article-title":"Quality of life questionnaires for children with cancer and childhood cancer survivors: a review of the development of available measures","volume":"18","author":"Klassen","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.canep.2022.102203_bib107","first-page":"3143","article-title":"Assessing quality of life in long-term cancer survivors: a review of available tools","volume":"21","author":"Muzzatti","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.canep.2022.102203_bib108","article-title":"Timeliness of diagnosis of breast and cervical cancers and associated factors in low-income and middle-income countries: a scoping review","volume":"12","author":"Nnaji","year":"2021","journal-title":"BMJ Open"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782122001084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782122001084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:31:14Z","timestamp":1761802274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782122001084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":108,"alternative-id":["S1877782122001084"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2022.102203","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global burden of ototoxic hearing loss associated with platinum-based cancer treatment: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2022.102203","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102203"}}